George A. Samuel
General Counsel & Company SecretaryMr. George A. Samuel, III, J.D., has been General Counsel & Company Secretary of Lineage Cell Therapeutics, Inc. since September 01, 2021. He joined the Lineage Cell Therapeutics, Inc. in September 01, 2021. He is a Vice President and General Counsel at TrovaGene, Inc. Mr. Samuel most recently served as Director, Senior Counsel for Lytx, Inc., where he managed the commercial legal operations for an international video telematics SaaS company. Prior to that, Mr. Samuel served as VP, General Counsel and Corporate Secretary for Cardiff Oncology, Inc. (formerly known as Trovagene, Inc.), a clinical-stage biotechnology company focused on developing treatments in oncology. While at Cardiff Oncology, he advised on strategic, business development and operational decisions; oversaw capital raising efforts, regulatory compliance as well as SEC reporting; and managed intellectual property, including technology transfer and licensing. Mr. Samuel has also practiced corporate law at major law firms, including DLA Piper LLP and Cooley LLP, where he served as outside counsel to public and private companies in a variety of commercial transactions. Mr. Samuel received a J.D. from Columbia University School of Law, and a B.A. in Philosophy from Tufts University. He is a member of the State Bar of California and New York.
Positions
- Company NameLineage Cell Therapeutics, Inc.Stock CodeLCTXPositionGeneral Counsel & Company SecretaryColleagues
- BMBrian M. CulleyCEO, President & Director
- MHMichael H. MulroyIndependent Chairman
- JAJill Ann HoweChief Financial Officer
- ICIoana C. HoneVP of Corporate Communications & Director of Investor Relations
- CHCharlotte HubbertVice President of Corporate Strategy & Development
- NCNeal Clifton BradsherIndependent Director
- DJDeborah J. AndrewsIndependent Director
- ACAngus C. RussellIndependent Director
